Organism name | Eugenia sandwicensis |
---|---|
Genus | Eugenia |
Family | Myrtaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Eugenia |
---|---|
Linked NCBI taxonomy ID | 119950 |
Linked level | genus |
Family in NCBI taxonomy | Myrtaceae |
---|---|
ID | 3931 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00030742
![]() |
Maslinic acid
/ Crategolic acid / 2alpha,3beta-Dihydroxyolean-12-en-28-oic acid |
CHEMBL201515
CHEMBL383749 CHEMBL482673 CHEMBL577380 |
C412811
|
8 / 5 / 4 | No. 13 | No. 51 |
![]() |
|
C00030459
![]() |
Hederagenin
|
CHEMBL486400
CHEMBL492472 CHEMBL1436053 |
C025763
|
7 / 11 / 11 | No. 13 | No. 51 |
![]() |
|
C00029724
![]() |
Arjunolic acid
|
CHEMBL464466
CHEMBL1774425 CHEMBL1797308 |
C061640
|
2 / 0 / 0 | 0 / 2 | No. 13 | No. 51 |
![]() |
C00003741
![]() |
Betulinic acid
|
CHEMBL269277
CHEMBL71690 CHEMBL519059 CHEMBL1318530 CHEMBL2005635 |
C002070
|
34 / 17 / 14 | 10 / 2 | No. 23 | No. 51 |
![]() |
C00019308
![]() |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
![]() |
|
C00007558
![]() |
Syringaldehyde
/ 4-Hydroxy-3,5-dimethoxybenzaldehyde |
CHEMBL225303
|
C069665
|
No. 856 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00019308 C00030459 C00030742 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003741 C00029724 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003741 C00019308 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003741 C00030459 | 0 / 1 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00003741 C00030742 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00003741 C00019308 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00003741 C00030459 | 0 / 0 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003741 C00029724 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003741 C00030459 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003741 C00030459 | 11 / 10 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00019308 C00030459 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00003741 C00030742 | 0 / 0 |
P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00003741 C00030459 | 0 / 0 |
P11217 | Glycogen phosphorylase, muscle form | Enzyme | C00030742 | 1 / 1 |
P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00030742 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00003741 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003741 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003741 | 0 / 0 |
P08151 | Zinc finger protein GLI1 | Unclassified protein | C00003741 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00003741 | 0 / 0 |
Q02156 | Protein kinase C epsilon type | Eta | C00003741 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003741 | 0 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003741 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00003741 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00003741 | 1 / 1 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00003741 | 0 / 0 |
P00734 | Prothrombin | S1A | C00019308 | 4 / 2 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00030742 | 4 / 2 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00003741 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003741 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00003741 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003741 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00003741 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003741 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003741 | 2 / 0 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00030742 | 0 / 1 |
P29350 | Tyrosine-protein phosphatase non-receptor type 6 | Tyr | C00030742 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003741 | 1 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003741 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00003741 | 0 / 0 |
Q9UBT2 | SUMO-activating enzyme subunit 2 | Enzyme | C00003741 | 0 / 0 |
Q9UBE0 | SUMO-activating enzyme subunit 1 | Unclassified protein | C00003741 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003741
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003741
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00003741
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003741
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003741
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003741
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003741
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003741
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00003741
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00003741
|
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232600 | Glycogen storage disease v |
P11217
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P11217
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D008103 | Liver Cirrhosis |
C00003741
|
D008545 | Melanoma |
C00003741
|
D002493 | Central Nervous System Diseases |
C00019308
|
D003072 | Cognition Disorders |
C00019308
|
D013118 | Spinal Cord Diseases |
C00019308
|
D003928 | Diabetic Nephropathies |
C00029724
|
D007674 | Kidney Diseases |
C00029724
|